| Date | Title | Description | |
|---|---|---|---|
| 03 Nov 2021 | On buy-back programmes | The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. | Download |
| 16 Jul 2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | Download |
| 22 Jun 2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | Download |
| 22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
| 29 Apr 2021 | On business and financial situation | The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 19 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 12 April and 18 April 2024 | Download |
| 12 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 5 April and 11 April 2024 | Download |
| 05 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 28 March and 4 April 2024 | Download |
| 02 Apr 2024 | On business and financial situation | ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia | Download |
| 29 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 22 March and 27 March 2024 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 31 Jan 2020 | R&D: new licenses, patents and registered trademarks | The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union | Download |
| 08 Jan 2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2019 | Download |
| 20 Dec 2019 | Composition of the board of directors | The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees. | Download |
| 24 Nov 2019 | Strategic plans, profit forecasts and presentations | The Company releases the presentation related to its strategy update because of the 2019 Investor Day. | Download |
| 07 Nov 2019 | Information on P&L | ROVI releases the press release related to the first nine months 2019 financial results | Download |